Business and Finance2 months ago
Novo Nordisk Faces Slowing Demand for Wegovy as Eli Lilly (LLY) Competition Intensifies
Novo Nordisk, the Danish pharmaceutical giant behind the blockbuster weight-loss drug Wegovy and diabetes treatment Ozempic, is facing its toughest challenge yet. According to a recent...
